Oric Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Oric Pharmaceuticals Inc
TickerORIC
CIK #0001796280
CUSIP68622P109
SectorLife Sciences - Pharmaceutical Preparations
Address240 E Grand Ave 2Nd Floor, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2024
[0001796280] 10-K
[0001796280] 10-Q
[0001796280] 3
[0001796280] 4
[0001796280] 8-K
[0001796280] SC 13D
[0001796280] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
ProSight Management LP Oric Pharmaceuticals Inc [2023-06-12] 5.1
Millennium Management LLC Oric Pharmaceuticals Inc [2023-01-20] 5.4
Pfizer Inc Oric Pharmaceuticals Inc [2022-12-29] 58.0
BlackRock Inc Oric Pharmaceuticals Inc [2022-07-08] 2.0
Victory Capital Management Inc Oric Pharmaceuticals Inc [2022-02-02] 5.84
Column Group II LP Oric Pharmaceuticals Inc [2021-02-16] 13.1
BlackRock Inc Oric Pharmaceuticals Inc [2021-02-02] 5.3
FMR LLC Oric Pharmaceuticals Inc [2020-05-11] 0.0
OrbiMed Advisors LLC Oric Pharmaceuticals Inc [2020-05-01] 0.2
EcoR1 Capital LLC Oric Pharmaceuticals Inc [2020-05-01] 8.8
Topspin Fund LP Oric Pharmaceuticals Inc [2020-04-29] 11.51
Form 3/4/5 Filer 2011 - 2024
Piscitelli Dominic
Oric Pharmaceuticals, Inc.
Multani Pratik S
Chacko Jacob
Pfizer Inc
Dier Mardi
You Angie
Kunkel Lori Anne
Heyman Richard A.
Hoerter Steven L.
Column Group LLC
Goeddel David V
Column Group II LP
Column Group II GP, LP
Svennilson Peter
Gordon Carl L
Scheller Richard H
OrbiMed Advisors LLC
OrbiMed Capital GP VI LLC
LG Management, LLC
Topspin Biotech Fund II, L.P.
Topspin Fund L.P.
Guthart Leo
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2023-03-31] DFND 4,005,487.0 4,007,099.0
Column Group LLC [2023-03-31] SOLE 3,568,181.0 3,568,181.0
EcoR1 Capital LLC [2023-03-31] SOLE 3,418,068.0 3,418,068.0
Millennium Management LLC [2023-03-31] SOLE 2,267,642.0 2,267,642.0
Alkeon Capital Management LLC [2023-03-31] SOLE 2,014,241.0 2,014,241.0
Suvretta Capital Management LLC [2023-03-31] SOLE 1,902,643.0 1,902,643.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,631,906.0
ProSight Management LP [2023-03-31] SOLE 1,545,000.0 1,545,000.0
SilverArc Capital Management LLC [2023-03-31] SOLE 1,435,945.0 1,435,945.0
OrbiMed Advisors LLC [2023-03-31] SOLE 1,374,468.0 1,374,468.0
Boxer Capital, LLC [2023-03-31] OTR 1,054,000.0 1,054,000.0
Invus Financial Advisors LLC [2023-03-31] SOLE 1,007,575.0 1,007,575.0
Euclidean Capital LLC [2023-03-31] SOLE 747,550.0 747,550.0
BlackRock Inc. [2023-03-31] SOLE 689,132.0 690,514.0
Memorial Sloan Kettering Cancer Center [2023-03-31] SOLE 602,272.0 602,272.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 578,303.0 578,303.0
Monaco Asset Management SAM [2023-03-31] SOLE 551,749.0 551,749.0
Alkeon Capital Management LLC [2023-03-31] OTR 0.0 385,011.0
UBS OConnor LLC [2023-03-31] DFND 362,707.0 362,707.0
Renaissance Technologies LLC [2023-03-31] SOLE 344,100.0 344,100.0
Geode Capital Management LLC [2023-03-31] DFND 307,422.0 307,422.0
Susquehanna International Group LLP [2023-03-31] DFND 238,438.0 271,938.0
ArrowMark Colorado Holdings LLC [2023-03-31] SOLE 255,732.0 255,732.0
Jane Street Group LLC [2023-03-31] DFND 173,159.0 173,159.0
DAFNA Capital Management LLC [2023-03-31] SOLE 170,326.0 170,326.0
Victory Capital Management Inc [2023-03-31] SOLE 158,430.0 158,430.0
GSA Capital Partners LLP [2023-03-31] SOLE 142,405.0 142,405.0
Citadel Advisors LLC [2023-03-31] DFND 134,903.0 134,903.0
Newtyn Management LLC [2023-03-31] SOLE 133,999.0 133,999.0
Acadian Asset Management LLC [2023-03-31] DFND 130,655.0 130,655.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com